SciCombinator

Discover the most talked about and latest scientific content & concepts.

G Giovannoni, JA Cohen, AJ Coles, HP Hartung, E Havrdova, KW Selmaj, DH Margolin, SL Lake, SM Kaup, MA Panzara and DA Compston
Abstract
To characterize effects of alemtuzumab treatment on measures of disability improvement in patients with relapsing-remitting multiple sclerosis (RRMS) with inadequate response (≥1 relapse) to prior therapy.
Tweets*
23
Facebook likes*
3
Reddit*
0
News coverage*
84
Blogs*
3
SC clicks
0
Concepts
Better, Improve, Multiple sclerosis
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com